# A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients

> **NCT03284242** · EARLY_PHASE1 · COMPLETED · sponsor: **Roberto Gedaly** · enrollment: 9 (actual)

## Conditions studied

- End Stage Renal Disease
- Kidney Transplant

## Interventions

- **DRUG:** Treg

## Key facts

- **NCT ID:** NCT03284242
- **Lead sponsor:** Roberto Gedaly
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-15
- **Primary completion:** 2024-04-10
- **Final completion:** 2024-04-10
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2024-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03284242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03284242, "A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03284242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*